Amity In-Prison Therapeutic Community: Preliminary Five-Year Outcomes

Slides:

Advertisements

Similar presentations

Dallas County SAFPF Re-Entry Courts Outcome Study

Advertisements

M. Fe Caces, Ph. D. Statistician/Demographer Office of National Drug Control Policy Executive Office of the President Washington, DC June 2003 Treatment.

Development and Implementation of a Recovery-Based System: Comparison of Instruments for Assessing Recovery Jeanette M. Jerrell, Ph.D. Professor of Neuropsychiatry,

Role of client early treatment evaluation in post-treatment recovery promoting cognitions and activities A. Laudet, K. Morgen & V. Stanick National Development.

Hit and Miss: A Study of Post-Release Support Brendan Quinn and Amy Kirwan 23 rd June 2009.

Weisburd, Lawton, Ready, Rudes, Cave, and Nelson Presented by Breanne Cave 1.

1 Managing Substance Use Disorders (SUDS) as a Chronic Condition Michael L. Dennis, Ph.D. Chestnut Health Systems 720 W. Chestnut, Bloomington, IL 61701,

Mental Health Service Needs and Service Use of Juvenile Detainees Karen Abram, Ph.D. Psycho-Legal Studies Program Northwestern University Feinberg School.

Oklahoma Department of Corrections DUI Offender Profile

1 Intervening in the Recovery Process Michael L. Dennis, Ph.D. Christy K Scott, Ph.D. Chestnut Health Systems, Bloomington &Chicago, IL U.S.A. Presentation.

COMPASS: COMMUNITY PARTNERSHIPS AND SOCIAL SERVICES FOR PEOPLE LIVING WITH HIV LEAVING THE JAIL SETTING Emily Patry, BS The Miriam Hospital, Providence,

Gender Differences in Health Status Among Opiate Users in a 25-Year Follow-up Study Christine Grella & Luz Rodriguez UCLA Integrated Substance Abuse Programs.

Abstract People who enter substance abuse treatment under various degrees of legal pressure do at least as well at the end of treatment or at follow-up.

Background: The low retention rates among African Americans in substance abuse treatment (Milligan et al., 2004) combined with the limited number of treatments.

Differences in Characteristics of Heroin Inhalers and Injectors at Admission to Treatment J. C. Maxwell, R. T. Spence, & T. M. Bohman UT Center for Social.

Conducting Research in Challenging Times: California Parolee Reentry Court Evaluation Association of Criminal Justice Research, California March

Preliminary Findings: Recovery Center Outcome Study

Foster Youth and the Transition to Adulthood: Findings from the Midwest Study Mark Courtney, Principal Investigator Amy Dworsky, Project Director.

Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug Abuse What Do We Know? Drug Abuse.

Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug Abuse RESEARCH and TREATMENT Provide.

Re-Entry and Recidivism

ATLAS PROGRAM: HIV TESTING AND LINKAGE IN THE CUYAHOGA COUNTY CORRECTIONS CENTER Rachel Ciomcia, LISW-Project Coordinator Jenice Contreras, Director of.

Engaging Moms Program (EMP): Serving “the best interests of the child” by Improving Maternal Functioning Gayle A Dakof & Elliette Duarte University of.

 Nationally representative samples of prison inmates (2004, N = 18,200) and jail inmates (2002, N = 7,000)  Interviewers asked each inmate about symptoms.

ENROLLING JUSTICE INVOLVED POPULATIONS: POLICY IMPLICATIONS LINDSAY NELSON KENTUCKY PRIMARY CARE ASSOCIATION.

Journal Club Alcohol and Health: Current Evidence November–December 2004.

Prison Based Motivational Intervention Therapy for Problem Drinkers; Impact of feasibility study in HMP Altcourse Emma Pennington Research Associate CAIS.

® Introduction Low Back Pain Remedies and Procedures: Helpful or Harmful? Lauren Lyons, Terrell Benold, MD, Sandra Burge, PhD The University of Texas Health.

Psychopharmacotherapy in Correctional Institutions Robert P. Schwartz, M.D. Friends Research Institute Supported by NIDA R01 DA (PI: Kinlock)

UCLA Drug Abuse Research CenterForever Free Evaluation Forever Free Substance Abuse Treatment Program Outcomes Study Michael Prendergast, Ph.D., Principal.

UCLA Integrated Substance Abuse Programs (ISAP). CSAT MTP Project Goals: To study the clinical effectiveness of the Matrix Model To study the clinical.

Frequency and type of adverse events associated with treating women with trauma in community substance abuse treatment programs T. KIlleen 1, C. Brown.

NIDA Grants: U10DA015831, K24DA022288, U10DA020024, K23DA022297, U10DA Predictors of Outcome in the Multi-Site CTN Prescription Opioid Addiction.

The Rhode Island Experience Ellen Evans Alexander Assistant Director RI Department of Corrections.

C:\laam\lamAPA.ppt 8/04/98 Heroin Addiction Treatment: A Comparison of Methadone and LAAM M. Douglas Anglin, Ph.D. Douglas Longshore, Ph.D. Jeffrey J.

Criminal Justice Reform in California Challenges and Opportunities Mia Bird Northern California Grantmakers Annual Conference – From Ideas to Action May.

PowerPoint Template ©2009 Texas Christian University, Center for Instructional Services. For Educational Use Only. Content is the property of the presenter.

In-Jail Therapeutic Community Drug Treatment: Impact on Rearrest Rates James K. Cunningham, Ph.D. Research and Education on Addiction and Community Health.

METHODS Sample n=245 Women, 24% White, 72% Average age, 36.5 Never married, 51% Referral Sources (%) 12-Month DSM-IV Substance Dependence Prior to Entering.

Outcomes of Treatment for Methamphetamine Use: LA County (“Treatment-as-Usual”) M.-L. Brecht UCLA Integrated Substance Abuse Programs CATES 3/30/2004.

Evaluations of CDCR Substance Abuse Programs: Lessons Learned Michael L. Prendergast, Ph.D. Criminal Justice Research Group UCLA Integrated Substance Abuse.

Recovery Support Services and Client Outcomes: What do the Data Tell Us? Recovery Community Services Program Grantee Meeting December 14, 2007.

North Carolina TASC NC TASC Bridging Systems for Effective Offender Care Management.

CARIBBEAN BASIN AND HISPANIC ADDICTION TECHNOLOGY TRANSFER CENTER Effects of a Two-facet Intervention to Reduce HIV Risk Behaviors Among Hispanic Drug.

Michael Bogenschutz, Dennis Donovan, Cameron Crandall, Robert Lindblad, Raul Mandler, Harold Perl, Alyssa Forcehimes 1 Screening Procedures to Identify.

Salient Factor Score CTSFS99. What it is How to use it.

The Sexual Practices of Inhalant Nitrate & Methamphetamine Users Perry N. Halkitis, M.S., Ph.D. Michael T. Maurer, Ph.D., M.H.A. New York University Presented.

Patient and Staff Satisfaction in Outpatient Substance Abuse Treatment Programs A. Kulaga 1, B. McClure 1, J. Rotrosen 1, P. Crits-Christoph 2, S. Ring-Kurtz.

Introduction Results and Conclusions On demographic variables, analyses revealed that ATR clients were more likely to be Hispanic and employed, whereas.

Psychosocial Changes Among Special Populations in a Prison-based Therapeutic Community David Farabee, Michael Prendergast, & Jerome Cartier University.

  With 2.2 million inmates, America has more prisoners behind.

UCLA Integrated Substance Abuse Programs Amity In-Prison Therapeutic Community: Five-Year Outcomes Association of Criminal Justice Research (CA) Sacramento,

Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.

Introduction Results Treatment Needs and Treatment Completion as Predictors of Return-to-Prison Following Community Treatment for Substance-Abusing Female.

Criminal Justice Drug Abuse Treatment Studies A National Network for the Study of Drug Abuse Services for Offenders NIDA Natl. Developmental Res. Inst.

METHADONE VS. NON-METHADONE PATIENTS IN A THERAPEUTIC COMMUNITY: TEST OF EQUIVALENCY James L. Sorensen 1,2, S. Andrews 1,2, K. L. Delucchi 1,3, B. Greenberg.

Preparing Communities for Re-Entry of Offenders with Mental Illness: The ACTION Approach Presented by: Andradene Lowe & Kris Wilson.

Methamphetamine Use Among Offenders Association for Criminal Justice Research (CA) March 17, 2005 Jerry Cartier / David Farabee / Michael Prendergast University.

Efficacy of a “One-Shot” Computerized, Individualized Intervention to Increase Condom Use and Decrease STDs among Clinic Patients with Main Partners Diane.

UCLA Integrated Substance Abuse ProgramsForever Free Evaluation Residential Substance Abuse Treatment Programs for Women Laurie Bright, National Institute.

1 Assessment Guided Life Planning: The San Diego SB 618 Prisoner Reentry Experience Criminal Justice Research Division Darlanne Hoctor Mulmat

Performance Measurement Tool (PMT) What Data Tells Us About Current RSAT Programming Presented by: Jimmy Steyee New Orleans, LA July 17, 2015.

1 CLEAN COURT OUTCOME STUDY January, 2005 Charlene Rhyne, PhD.

Changing adolescent substance use and criminal activity in juvenile drug court: Improving outcomes through family-based treatment Gayle Dakof, Craig Henderson,

Medication Adherence and Substance Abuse Predict 18-Month Recidivism among Mental Health Jail Diversion Program Clients Elizabeth N. Burris 1, Evan M.

JAIL AND SHELTER USE IN THE RICHMOND REGION Margot Ackermann, Ph.D. (803) x11.

Approaches to Linking Process and Outcome Data in a Cross-Site Evaluation Laura Elwyn, Ph.D. Kristin Stainbrook, Ph.D. American Evaluation Association.

PURPOSE BACKGROUND RESULTS STUDY DESIGN & METHODS HIV Risk Behaviors Among Male Prisoners Participating in a Randomized Clinical Trial of Methadone Maintenance.

The War on Drugs AKA the War on Blacks and Browns

Kristin Stainbrook, PhD

Presentation transcript:

Amity In-Prison Therapeutic Community: Preliminary Five-Year Outcomes Michael L. Prendergast, Ph.D, Principal Investigator Elizabeth A. Hall, Ph.D., Project Director Harry Wexler, Ph.D., Co-Investigator Research Supported by NIDA Grant R01 DA11483 UCLA Integrated Substance Abuse Programs

UCLA Integrated Substance Abuse Programs Aims To assess long-term post-treatment outcomes of a prison-based TC program To determine differential outcomes within selected subgroups To examine factors that contribute to the long-term recovery of those who did not participate in treatment UCLA Integrated Substance Abuse Programs

UCLA Integrated Substance Abuse Programs Aims To conduct secondary analyses of data previously collected To conduct a cost analysis of the prison TC program and the TC continuing care program UCLA Integrated Substance Abuse Programs

UCLA Integrated Substance Abuse Programs Subjects 715 inmates enrolled in or on a waiting list for a prison-based therapeutic community drug treatment program (1993-1995) Randomly selected comparison group Housed in a Level 3 prison in San Diego Those completing treatment were eligible for TC aftercare at Amity Vista upon release UCLA Integrated Substance Abuse Programs

UCLA Integrated Substance Abuse Programs Subjects Male White 37.8%, Hispanic 30.1%, African American 22.4% Average age at follow up: 38 years (range, 26 to 72) Low educational attainment Primarily users of cocaine, methamphetamine, and heroin Highly violent, with 75% having committed assault, kidnapping, rape, or murder Average number of arrests (lifetime) at baseline: 27 Average number of incarcerations (lifetime) at baseline: 17 Average number of years in prison (lifetime) at baseline: 6 UCLA Integrated Substance Abuse Programs

UCLA Integrated Substance Abuse Programs Methods Five-year follow-up interviews : 576 completed (80% of original sample) Face-to-face Many interviews were conducted in jails and prisons Modified NDRI follow-up instrument and DARC’s Natural History instrument Urine samples (31% of completed sample) Hair samples (19% of completed sample) UCLA Integrated Substance Abuse Programs

UCLA Integrated Substance Abuse Programs Findings at Years 1, 2, and 3 Calculated from Lowe, Wexler, & Peters (1998), Wexler, De Leon, Kressel, & Peters (1999) Wexler Melnick, Lowe, & Peters (1999). UCLA Integrated Substance Abuse Programs

UCLA Integrated Substance Abuse Programs Results Self-reported drug use in past year for those in prison/jail less than 30 days (N=180)* *p < .05 UCLA Integrated Substance Abuse Programs

Results Treatment groups: Self-reported drug use past year for those in prison/jail less than 30 days (N=113)1 1p = .12 UCLA Integrated Substance Abuse Programs

UCLA Integrated Substance Abuse Programs Results Urinalysis (N=179)1 1 n.s. UCLA Integrated Substance Abuse Programs

Results 1 n.s. Treatment groups: Urinalysis (N=109) 1 UCLA Integrated Substance Abuse Programs

Results Mean days incarcerated past year1 1 n.s. UCLA Integrated Substance Abuse Programs

Results Treatment groups: Mean days incarcerated past year*** UCLA Integrated Substance Abuse Programs

UCLA Integrated Substance Abuse Programs Results Employed past year1 1 n.s. UCLA Integrated Substance Abuse Programs

Results Treatment groups: Employed past year*** ***p < .0001 UCLA Integrated Substance Abuse Programs

Results Received treatment past year1 1 n.s. UCLA Integrated Substance Abuse Programs

Results Treatment groups: Received treatment past year1 1 n.s. UCLA Integrated Substance Abuse Programs

UCLA Integrated Substance Abuse Programs Discussion 5 year results are similar to 3 year results: No difference in outcomes between treatment and comparison groups. Among treatment groups, those who completed Vista TC aftercare performed significantly better on employment and incarceration measures. UCLA Integrated Substance Abuse Programs

UCLA Integrated Substance Abuse Programs Future Analyses Differential effects by severity of use risk status psychological status motivation subsequent treatment Cost analysis UCLA Integrated Substance Abuse Programs